SG11202007860XA - Pharmaceutical composition comprising timolol - Google Patents
Pharmaceutical composition comprising timololInfo
- Publication number
- SG11202007860XA SG11202007860XA SG11202007860XA SG11202007860XA SG11202007860XA SG 11202007860X A SG11202007860X A SG 11202007860XA SG 11202007860X A SG11202007860X A SG 11202007860XA SG 11202007860X A SG11202007860X A SG 11202007860XA SG 11202007860X A SG11202007860X A SG 11202007860XA
- Authority
- SG
- Singapore
- Prior art keywords
- timolol
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- TWBNMYSKRDRHAT-RCWTXCDDSA-N (S)-timolol hemihydrate Chemical compound O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 TWBNMYSKRDRHAT-RCWTXCDDSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229960004605 timolol Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18164563 | 2018-03-28 | ||
| EP18185436 | 2018-07-25 | ||
| PCT/EP2019/057429 WO2019185543A1 (en) | 2018-03-28 | 2019-03-25 | Pharmaceutical composition comprising timolol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202007860XA true SG11202007860XA (en) | 2020-09-29 |
Family
ID=65818028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202007860XA SG11202007860XA (en) | 2018-03-28 | 2019-03-25 | Pharmaceutical composition comprising timolol |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210121471A1 (es) |
| EP (1) | EP3773469A1 (es) |
| JP (1) | JP7496778B2 (es) |
| KR (1) | KR20200136403A (es) |
| CN (1) | CN111867560B (es) |
| AU (1) | AU2019246035B2 (es) |
| BR (1) | BR112020017841A2 (es) |
| CA (1) | CA3091313A1 (es) |
| IL (1) | IL276888B1 (es) |
| MX (1) | MX2020010078A (es) |
| SG (1) | SG11202007860XA (es) |
| WO (1) | WO2019185543A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2019003363A (es) | 2016-09-22 | 2019-10-02 | Novaliq Gmbh | Composiciones farmaceuticas para usarse en la terapia de la blefaritis. |
| AU2017329983B2 (en) | 2016-09-23 | 2022-05-05 | Novaliq Gmbh | Ophthalmic compositions comprising ciclosporin |
| JP2020535156A (ja) | 2017-09-27 | 2020-12-03 | ノバリック ゲーエムベーハー | 眼疾患の治療に使用するためのラタノプロストを含む眼科用組成物 |
| JP7353292B2 (ja) | 2018-03-02 | 2023-09-29 | ノバリック ゲーエムベーハー | ネビボロールを含む医薬組成物 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19536504C2 (de) * | 1995-09-29 | 1999-09-23 | H Meinert | Verwendung fluorierter Alkane |
| US6335335B2 (en) | 1997-11-05 | 2002-01-01 | Senju Pharmaceutical Co., Ltd. | Prolonged-action eye drop |
| TWI298257B (en) * | 2001-05-31 | 2008-07-01 | Allergan Inc | Hypotensive lipid and timolol compositions and methods of using same |
| US7030149B2 (en) * | 2002-04-19 | 2006-04-18 | Allergan, Inc. | Combination of brimonidine timolol for topical ophthalmic use |
| AU2002325220A1 (en) * | 2002-05-24 | 2003-12-12 | Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh | Drop-forming ophthalmic gel preparation comprising diclofenamide and timolol |
| US20070238732A1 (en) * | 2006-04-10 | 2007-10-11 | Allergan, Inc. | Brimonidine and timolol compositions |
| US8492334B2 (en) * | 2007-06-21 | 2013-07-23 | Yale University | Sustained intraocular delivery of drugs from biodegradable polymeric microparticles |
| EP2444063A1 (en) * | 2010-10-20 | 2012-04-25 | Novaliq GmbH | Liquid pharmaceutical compositions for the delivery of active ingredients |
| EP2462921A1 (en) * | 2010-11-11 | 2012-06-13 | Novaliq GmbH | Liquid pharmaceutical compositions for the treatment of a posterior eye disease |
| JP2012250951A (ja) * | 2011-06-06 | 2012-12-20 | Santen Pharmaceut Co Ltd | アデノシン誘導体とプロスタグランジン類とβ受容体遮断薬の組合せ剤 |
| EP3209331B1 (en) * | 2014-10-20 | 2023-07-12 | Sentiss Pharma Private Limited | Ophthalmic solution |
| WO2016082644A1 (en) * | 2014-11-26 | 2016-06-02 | The University Of Hong Kong | A semifluorinated alkane based cleaner for removing emulsified droplets in the eye to reduce the complications associated with the emulsification of silicone oil |
| PT3442480T (pt) * | 2016-06-23 | 2019-12-23 | Novaliq Gmbh | Método de administração tópica |
-
2019
- 2019-03-25 MX MX2020010078A patent/MX2020010078A/es unknown
- 2019-03-25 US US17/041,758 patent/US20210121471A1/en active Pending
- 2019-03-25 EP EP19711929.0A patent/EP3773469A1/en active Pending
- 2019-03-25 CN CN201980018538.6A patent/CN111867560B/zh active Active
- 2019-03-25 SG SG11202007860XA patent/SG11202007860XA/en unknown
- 2019-03-25 KR KR1020207027430A patent/KR20200136403A/ko not_active Application Discontinuation
- 2019-03-25 CA CA3091313A patent/CA3091313A1/en active Pending
- 2019-03-25 WO PCT/EP2019/057429 patent/WO2019185543A1/en unknown
- 2019-03-25 BR BR112020017841-1A patent/BR112020017841A2/pt unknown
- 2019-03-25 AU AU2019246035A patent/AU2019246035B2/en active Active
- 2019-03-25 IL IL276888A patent/IL276888B1/en unknown
- 2019-03-25 JP JP2020549581A patent/JP7496778B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3773469A1 (en) | 2021-02-17 |
| IL276888B1 (en) | 2024-08-01 |
| WO2019185543A1 (en) | 2019-10-03 |
| US20210121471A1 (en) | 2021-04-29 |
| CN111867560B (zh) | 2024-08-13 |
| JP7496778B2 (ja) | 2024-06-07 |
| CA3091313A1 (en) | 2019-10-03 |
| CN111867560A (zh) | 2020-10-30 |
| AU2019246035A1 (en) | 2020-09-10 |
| IL276888A (en) | 2020-10-29 |
| BR112020017841A2 (pt) | 2020-12-22 |
| KR20200136403A (ko) | 2020-12-07 |
| JP2021518352A (ja) | 2021-08-02 |
| MX2020010078A (es) | 2021-02-26 |
| AU2019246035B2 (en) | 2024-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279442A (en) | Pharmaceutical preparations that include meloxicam | |
| GB201807942D0 (en) | Pharmaceutical formulation | |
| IL269061A (en) | A pharmaceutical preparation containing Selexifag | |
| PL3452075T3 (pl) | Oftalmiczna kompozycja farmaceutyczna | |
| IL276888A (en) | Pharmaceutical compositions containing timolol | |
| GB201911517D0 (en) | Pharmaceutical composition | |
| GB201804548D0 (en) | Pharmaceutical compositions | |
| EP3851121A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING A HUMAN ANTI-IL-33 MONOCLONAL ANTIBODY | |
| IL290894A (en) | pharmaceutical preparation | |
| GB201808462D0 (en) | Pharmaceutical formulation | |
| GB201807053D0 (en) | Pharmaceutical composition | |
| GB201808571D0 (en) | Pharmaceutical compositions | |
| SG11202103374TA (en) | Pharmaceutical composition | |
| GB201808567D0 (en) | Pharmaceutical compositions | |
| EP3603641A4 (en) | PHARMACEUTICAL COMPOSITION WITH A DUSP1 INHIBITOR | |
| IL279707A (en) | A pharmaceutical preparation that includes a polypeptide | |
| SG11202110315SA (en) | Pharmaceutical composition | |
| PL3908321T3 (pl) | Kompozycja farmaceutyczna | |
| IL280989A (en) | Pharmaceutical preparations that include integration-promoting peptides | |
| GB201906473D0 (en) | Pharmaceutical formulation | |
| EP3664798A4 (en) | PHARMACEUTICAL COMPOSITION WITH ELIGLUSTAT | |
| ZA202006541B (en) | Pharmaceutical composition comprising brexpiprazole | |
| IL285728A (en) | Pharmaceutical composition | |
| GB201912686D0 (en) | Pharmaceutical composition | |
| GB201908003D0 (en) | Pharmaceutical composition |